Fact checked byKristen Dowd

Read more

January 06, 2025
5 min read
Save

Alcohol associated with more severe anaphylaxis in nut allergy

Fact checked byKristen Dowd
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Key takeaways:

  • Peanuts, shellfish and tree nuts were the most common food triggers in anaphylaxis.
  • The combination of nuts used in drinks and alcohol’s role as an antihistamine trigger may lead to more severe reactions.

Symptomology varies among adults with anaphylaxis depending on the trigger, according to a study published in International Archives of Allergy and Immunology.

For example, patients with nut allergies may experience more severe reactions when they drink alcohol, Roy Khalaf, fourth-year medical student, Faculty of Medicine and Health Sciences, McGill University, and colleagues wrote.

The most common anaphylaxis triggers among adults included food (53.7%), drugs (20.2%) and venom (6.3%).
Data were derived from Khalaf R, et al. Int Arch Allergy Immunol. 2024;doi:10.1159/000542115.

“The majority of studies in the literature concentrate on pediatric anaphylaxis, leaving a gap in data regarding adult cases,” Khalaf told Healio.

Roy Khalaf

Moshe Ben-Shoshan, MD, MSc, assistant professor in the division of allergy and clinical medicine at McGill, led the collaboration with multiple physicians across Canada, Khalaf continued, including access to a database of adults with anaphylaxis presenting at EDs.

“These cases were stratified by triggers, allowing us to analyze their symptoms, co-morbidities and management approaches,” Khalaf said.

The study used data from the Cross Canada Anaphylaxis Registry, including eight EDs and one electronic medical service, for 1,135 adults (median age, 35.5 years; 38.4% men) who presented with anaphylaxis between April 2011 and November 2023.

Median ages by anaphylaxis trigger included 51.8 years for venom, 49.1 years for drug and 30.7 years for food. Specific median ages for food triggers ranged from a high of 52.1 years for soy to lows of 24.6 years for peanut and 23.5 years for milk.

Also, 15.1% of these patients had comorbid asthma. Anaphylaxis symptoms included pruritus (61.8%), angioedema (55.4%), urticaria (55.3%) and throat tightness (54.4%), with 23.7% of patients reporting no cutaneous symptoms.

Severity was mild for 7.6% of patients, moderate for 73.4% and severe for 18.9%, the researchers said, although they added that data came exclusively from EDs, so there was a lack of data pertaining to less severe reactions.

Food was the most common trigger (53.7%), followed by drugs (20.2%) and venom (6.3%). The most common triggers among foods included peanut (13.5%), shellfish (10.2%), tree nut (8.7%) and undefined nuts (4.1%).

The most common triggers among drugs were antibiotics (> 10.5%), with amoxicillin (4.7%) leading this category. Ingestion led to anaphylaxis in 77.3% of the drug-induced cases, and 18.8% of reactions were from parenteral administration.

The study indicated 168 hospital admissions following anaphylaxis as well, with 35.7% of these cases triggered by drugs, and 18 admissions to the ICU, with 44.4% of these cases triggered by drugs.

Hypotension was associated with drugs (adjusted OR = 1.2; 95% CI, 1.11-1.3), particularly intravenously administered drugs (aOR = 2.5; 95% CI, 1.32-4.41), and venom (aOR = 1.08; 95% CI, 1.03-1.13). Throat tightness was associated with tree nuts (aOR = 1.04; 95% CI, 1.01-1.06).

Triggers among the severe reactions included drugs (30.1%), venom (27.8%), tree nuts (18.9%), peanuts (14.6%), and undefined nuts (10.6%). Alcohol was associated with severe undefined nut-induced anaphylaxis as well (aOR = 1.51; 95% CI, 1.04-2.19).

“While alcohol is recognized as a cofactor that can exacerbate the severity of anaphylactic reactions, it was surprising to find a particular association with nut-induced anaphylaxis,” Khalaf said.

Explanations for the association between alcohol- and nut-induced anaphylaxis included ethanol’s vasodilation effect, which can lead to more severe shock from food allergy, the researchers said.

Further, the elevated acetaldehyde levels that follow alcohol consumption could induce airway mast cells to release histamine, increasing reaction severity, the researchers continued.

The nuts that often are used as a flavoring option in alcoholic drinks may combine with alcohol’s tendency to release antihistamines, also leading to more severe reactions, the researchers said.

“This observation raises questions about the safety of artificial flavorings in alcohol, which often contain nut-derived components, for patients with nut allergies,” Khalaf said.

Alcohol may be a cofactor in more severe forms of pollen food syndrome after the ingestion of tree nuts as well, the researchers added.

The researchers did not note any significant associations between severe reactions and exercise for any of the triggers, nor did they report any significant associations between alcohol consumption, asthma or other known comorbidities and other triggers.

“In our registry, 210 patients had a known allergy to food, alcohol or venom,” Khalaf said. “However, only 51 patients (24.3%) used epinephrine during their reaction outside the hospital.”

Khalaf remarked that this low percentage was notable because protocols recommend that anyone with a history of allergic reactions should carry an epinephrine autoinjector.

Outpatient treatment included epinephrine autoinjectors (27.8%), antihistamines (42.1%) and corticosteroids (8.7%). Treatment in the hospital also included epinephrine autoinjectors (43.3%), antihistamines (73.7%) and corticosteroids (74.8%).

Patients with peanut-induced anaphylaxis were more likely to get epinephrine autoinjectors in outpatient settings (aOR = 3.25; 95% CI, 2.03-5.2). Patients with anaphylaxis induced by tree nuts were more likely to get epinephrine autoinjectors with inpatient treatment (aOR = 2.05; 95% CI, 1.16-3.64).

During outpatient treatment, patients with drug-induced anaphylaxis were less likely to get antihistamine (aOR = 0.68; 95% CI, 0.48-0.89), and those with tree nut-induced anaphylaxis were more likely to get it (aOR = 1.81; 95% CI, 1.03-3.19).

Inpatient treatment including antihistamine was less likely for patients with anaphylaxis induced by peanuts (aOR = 0.46; 95% CI, 0.29-0.74) and tree nuts (aOR = 0.48; 95% CI, 0.26-0.83).

Overall, the researchers attributed food’s role as the leading trigger in anaphylaxis, particularly peanut, to the increased prevalence of food allergy worldwide. However, they cautioned that these associations do not imply a universal early warning system in anaphylaxis diagnosis.

Adding that validated diagnostic criteria for anaphylaxis remain crucial for swift diagnosis and appropriate treatment, the researchers reminded clinicians should practice clinical vigilance and focus on comprehensive assessment of each patient, with rapid administration of epinephrine when it is indicated.

“Educating patients on the proper use of epinephrine is one of the most crucial takeaways from anaphylaxis research,” Khalaf said.

The underuse of epinephrine observed in this study aligned with results from previous research, Khalaf continued, adding that he and his colleagues also have published findings indicating reductions in ICU mortality among patients with anaphylaxis who receive epinephrine prior to arriving at the hospital.

“Additionally, it is vital to emphasize the importance of teaching patients with known allergies to carefully check all ingredients, not only in their food but also in alcoholic beverages, as hidden flavorings may pose a risk,” Khalaf said.

Khalaf and his colleagues are now comparing anaphylaxis between elderly patients and non-elderly adults, and he reports that findings so far are “intriguing.” He expects this study to be published in the first quarter of 2025.

Reference:

For more information:

Roy Khalaf can be reached at roy.khalaf@mail.mcgill.ca.